Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago.

Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago.

Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease and mortality worldwide. Direct-acting antiviral (DAA) therapy leads to high cure rates. However, persons who inject drugs (PWID) are at risk for reinfection after cure and may require multiple DAA treatments to reach the...

Full description

Bibliographic Details
Main Authors: Eric Tatara, Alexander Gutfraind, Nicholson T Collier, Desarae Echevarria, Scott J Cotler, Marian E Major, Jonathan Ozik, Harel Dahari, Basmattee Boodram
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0264983

Internet

https://doi.org/10.1371/journal.pone.0264983

Similar Items